SPTBN2 and non-small cell lung carcinoma: KM plot of patients with NSCLC confirmed that elevated SPTBN2 expression was correlated with worse PFS prognosis in both the total PFS (Fig. 5B) and chemotherapy subgroup (Fig. 5C).